Linagliptin-Associated Alopecia and Bullous Pemphigoid
September 2019
in “
European Journal of Case Reports in Internal Medicine
”
Studysummary This case report describes a 68-year-old man who developed both alopecia areata and bullous pemphigoid after starting linagliptin for diabetes, suggesting a possible link with DPP-4 inhibitors.
Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
Read the full study on ejcrim.com →